Last reviewed · How we verify

NCT05426408: SMINC-3

Stockholm Myocardial Infarction with Nonobstructive Coronaries Study 3

Recruiting now NA Last updated 10 March 2025
What this trial tests

NA trial testing Cardiac magnetic resonance imaging to study coronary microvascular dysfunction in Myocardial Infarction with Nonobstructive Coronary Arteries in 85 participants. Currently enrolling.

Timeline
1 November 2022
Primary endpoint
31 December 2025
30 June 2026

Quick facts

Lead sponsorKarolinska Institutet
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment85
Start date1 November 2022
Primary completion31 December 2025
Estimated completion30 June 2026
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Karolinska Institutet

Who can join

Adults 35 to 79, any sex, with Myocardial Infarction with Nonobstructive Coronary Arteries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present pilot study will investigate the prevalence of CMD in an unselected cohort of patients with the working diagnosis MINOCA and to study if the diagnostic yield can be improved by adding adenosine to the CMR investigation. Patient will be their own controls.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Karolinska Institutet trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05426408.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing